269 related articles for article (PubMed ID: 16476057)
1. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
[TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus: exploiting the immune system.
Thorley-Lawson DA
Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
[TBL] [Abstract][Full Text] [Related]
5. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
[TBL] [Abstract][Full Text] [Related]
6. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
[TBL] [Abstract][Full Text] [Related]
7. Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection.
Ehlin-Henriksson B; Liang W; Cagigi A; Mowafi F; Klein G; Nilsson A
Immunology; 2009 Aug; 127(4):549-57. PubMed ID: 19604305
[TBL] [Abstract][Full Text] [Related]
8. Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation.
Zhang Y; Zhao H; He X; Zheng S; Wang T; Yan D; Sun J; Lu X; Wen J; Lau WY
Sci China Life Sci; 2012 Aug; 55(8):735-43. PubMed ID: 22932889
[TBL] [Abstract][Full Text] [Related]
9. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
10. Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers.
Titti F; Zamarchi R; Maggiorella MT; Sernicola L; Geraci A; Negri DR; Borsetti A; Menin C; D'Andrea E; Modesti A; Masuelli L; Verani P; Chieco-Bianchi L; Amadori A
J Med Virol; 2002 Sep; 68(1):129-40. PubMed ID: 12210440
[TBL] [Abstract][Full Text] [Related]
11. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
[TBL] [Abstract][Full Text] [Related]
12. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
Adhikary D; Behrends U; Moosmann A; Witter K; Bornkamm GW; Mautner J
J Exp Med; 2006 Apr; 203(4):995-1006. PubMed ID: 16549597
[TBL] [Abstract][Full Text] [Related]
13. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
Masucci MG; Szigeti R; Ernberg I; Hu CP; Torsteinsdottir S; Frade R; Klein E
Eur J Immunol; 1987 Jun; 17(6):815-20. PubMed ID: 3036539
[TBL] [Abstract][Full Text] [Related]
14. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
[TBL] [Abstract][Full Text] [Related]
15. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
16. Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins.
Huang S; Stupack D; Liu A; Cheresh D; Nemerow GR
Oncogene; 2000 Apr; 19(15):1915-23. PubMed ID: 10773881
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
18. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
19. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
Middeldorp JM; Pegtel DM
Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
[TBL] [Abstract][Full Text] [Related]
20. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]